Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,361–3,368 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Precigen Inc. PRGN-2009 in combination with pembrolizumab Newly diagnosed patients with HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) Phase 2 Ongoing Intravenous Oncology
PRF Technologies Ltd. PRF-110 Bunionectomy Phase 3 Data Released Topical Orthopedic
Processa Pharmaceuticals Inc. PCS499 Necrobiosis Lipoidica (NL) Phase 2b Ongoing oral #N/A
Processa Pharmaceuticals Inc. NGC-Gemcitabine (PCS3117) Solid tumors Phase 2b Trial Discontinued oral Oncology
Processa Pharmaceuticals Inc. NGC-Capecitabine (PCS6422) Breast cancer Phase 2 Data Released Oral Oncology
Processa Pharmaceuticals Inc. PCS12852 Gastroparesis Phase 2a Oral Gastroenterology
ProKidney Corp. Rilparencel (REGEN-006) - (PROACT 1) Type 2 Diabetes Phase 3 Ongoing Oral Endocrinology
ProKidney Corp. REGEN-008 - (REACT follow up) Chronic kidney disease (CKD) Phase 3 Enrollment Initiation intravenous N/A